ArticleBlood2016

Chemo-genomic interrogation of CEBPA mutated AML reveals recurrent CSF3R mutations and subgroup sensitivity to JAK inhibitors.

Vincent-Philippe Lavallée et al.PubMed ↗Publisher ↗

No numbers read from the abstract.